DUBLIN--(BUSINESS WIRE)--The "Drug Adherence Enhancement Market: Devices and Applications, 2018-2030" report has been added to ResearchAndMarkets.com's offering.
This report features an extensive study of the current landscape and future outlook of the growing market for smart medication adherence devices that are either already commercialized or under development. This burgeoning field presently offers a lot of opportunities to innovation-driven start-ups and investors.
Poor adherence to prescribed medications is a growing concern in the healthcare industry and is believed to be associated with negative health outcomes, inflated medical expenses, loss in productivity and, in certain cases, proves fatal as well. It has been estimated that, of the 4 billion annual prescriptions filled by the retailers in the US, approximately 50% are not taken by patients in accordance to physicians' instructions.
According to the US Centers for Disease Control and Prevention (CDC), failure to comply to prescribed treatment regimens has been identified as the cause of 125,000 premature deaths, up to 69% of all rehospitalizations, and results in approximately USD 100-300 billion worth of avoidable annual healthcare spending. Further, the US pharmaceutical industry alone is estimated to suffer a loss of approximately USD 188 billion per year, due to low adherence to prescribed medications.
Lack of compliance with therapy is particularly prevalent among elderly patients suffering from chronic clinical conditions, such as cardiovascular disorders, metabolic disorders (e.g., diabetes), neurological and central nervous system related disorders (e.g., multiple sclerosis and Parkinson's disease) and respiratory disorders (e.g., asthma and chronic obstructive pulmonary disease).
It is estimated that overall cost of treatment for non-adherent patients is at least twice as high as patients who adhere to recommended therapy regimens. Studies have demonstrated that every one percent improvement in medication adherence can help the US healthcare industry save up to USD 2 billion, resulting in an increase in pharmaceutical revenues by ~USD 4 billion.
As a result, several strategies have been/are being developed by pharmaceutical developers and healthcare providers to improve medication adherence. Such initiatives have been strengthened owing to the availability of connected devices and other digital solutions, which allow patients/healthcare providers to closely monitor and improve drug adherence.
Key Topics Covered
1. Preface
2. Executive Summary
3. Introduction
4. Smart Drug Delivery Devices: Current Market Landscape
5. Smart Accessory Devices And Packaging Systems: Current Market Landscape
6. Regulatory Landscape For Connected Drug Delivery Systems
7. Drug Delivery Devices: Company Profiles
8. Accessory Devices: Company Profiles
9. Case Studies
10. Product Competitiveness Analysis
11. Funding and Investment Analysis
12. Partnerships and Collaborations
13. Medication Adherence With Mobile Applications
14. Market Forecast
15. Conclusion
16. Executive Insights
Companies Featured
- 3M
- 5AM Ventures
- 7wire Ventures
- ApnaCare India
- Apoteket
- App Singularity
- Breed Reply
- Butterfly Ventures
- C3HealthLink
- caiocrol
- CSL Behring
- CUCO Health
- CuePath Innovation
- Curatio
- EnvoyHealth
- etectRx
- Eularis
- Healthcom
- Healtheoz
- HP Labs
- Luz Sade
- M Ventures
- NESTA
- PillDrill
- Pillo Health
- PRPL
- Qualcomm Life
- QuiO Technologies
- Quizora Media
- Serendipity Partners
- SHL Group
- TCGRx
- Zibdy
- Zipit Wireless
- and over 500 more...
For more information about this report visit https://www.researchandmarkets.com/research/k3s8hl/worldwide_drug?w=4
